Literature DB >> 7830847

Tumour lysis syndrome and acute renal failure in Burkitt's lymphoma. Description of 2 cases and a review of the literature on prevention and management.

J Veenstra1, R T Krediet, R Somers, L Arisz.   

Abstract

Two patients with Burkitt's lymphoma and acute renal failure are described, one with acute uric acid nephropathy and the other with acute renal failure due to hyperphosphataemia. Renal insufficiency caused by the precipitation of calcium phosphate salts only occurs after starting treatment of the lymphoma; uric acid nephropathy can also be present in an untreated patient. A uric acid/creatinine ratio in a random urine sample may help to confirm the diagnosis of acute uric acid nephropathy. Vigorous hydration, allopurinol and alkalinization of the urine have been advocated to prevent uric acid nephropathy. However, alkalinization may accelerate phosphate precipitation in the kidneys and thereby induce renal failure. Xanthine nephropathy may develop as a consequence of high doses of allopurinol. The administration of large volumes of fluid therefore remains the keystone in prevention of the tumour lysis syndrome.

Entities:  

Mesh:

Year:  1994        PMID: 7830847

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  3 in total

1.  Diffuse peritoneal lymphomatosis: atypical presentation of Burkitt lymphoma.

Authors:  Stephen Wong; Thomas Ray S Sanchez; Leonard E Swischuk; Frederick S Huang
Journal:  Pediatr Radiol       Date:  2008-11-20

2.  Acute kidney injury in lymphoma: a single centre experience.

Authors:  Muhammad Abdul Mabood Khalil; Hira Latif; Abdur Rehman; Waqar Uddin Kashif; Safia Awan; Zarghona Khalil; Uziar Mushtaq; Maria Ahmad; Muhammad Ashhad Ullah Khalil; Manickam Ranga Sami; Jackson Tan
Journal:  Int J Nephrol       Date:  2014-02-03

Review 3.  Tumor lysis syndrome in childhood malignancies.

Authors:  Wing Lum Cheung; Kam Lun Hon; Cheuk Man Fung; Alexander Kc Leung
Journal:  Drugs Context       Date:  2020-02-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.